Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Wezenla
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Wezenla 130mg/26ml concentrate for inf vials
0105030B0BDAAAA
|
Wezenla | Ustekinumab | Gastro-Intestinal System | No data available |
|
Wezenla 45mg/0.5ml inj pre-filled syringes
1305030D0BEABAB
|
Wezenla | Ustekinumab | Skin | No data available |
|
Wezenla 45mg/0.5ml solution for injection vials
1305030D0BEAAAA
|
Wezenla | Ustekinumab | Skin | No data available |
|
Wezenla 90mg/1ml inj pre-filled syringes
1305030D0BEACAC
|
Wezenla | Ustekinumab | Skin | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.